Trial Profile
Factors associated with bleeding events in hospitalised patients with end stage renal disease on hemodialysis treated with apixaban
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 03 Nov 2017
Price :
$35
*
At a glance
- Drugs Apixaban (Primary)
- Indications Kidney disorders
- Focus Therapeutic Use
- 03 Nov 2017 New trial record